Article metrics

Download PDFPDF

631 Development of highly efficacious and safe targeted cancer immunotherapy via IL12-based TMEkine™ platform

 

Online download statistics by month:

Online download statistics by month: November 2020 to September 2024

AbstractFullPdf
Nov 2020209033
Dec 20202408
Jan 20213803
Feb 202135010
Mar 202168012
Apr 202146010
May 202110010
Jun 20210016
Jul 20210010
Aug 20210010
Sep 20210012
Oct 202144031
Nov 202136030
Dec 20214409
Jan 202252021
Feb 20222108
Mar 20225407
Apr 202248016
May 202228014
Jun 20223408
Jul 20223705
Aug 20224108
Sep 20221403
Oct 20223301
Nov 20222004
Dec 20222401
Jan 20232000
Feb 20232605
Mar 20232403
Apr 20232407
May 20232205
Jun 202326011
Jul 20232003
Aug 20231602
Sep 20231602
Oct 20231403
Nov 20233005
Dec 20236204
Jan 2024400
Feb 20242201
Mar 20244404
Apr 20241602
May 20241601
Jun 20242602
Jul 20243802
Aug 20242604
Sep 20242603
Total14780369